BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34233977)

  • 1. Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study.
    Chang TS; Chang KC; Chen WM; Hsu NT; Lee CY; Lin YC; Huang WC; Chiu WN; Hu JH; Huang TJ; Chen MY; Lu SN
    BMJ Open; 2021 Jul; 11(7):e046115. PubMed ID: 34233977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver Disease Screening and Hepatitis C Virus Elimination in Taiwan Rural Indigenous Townships: Village-By-Village Screening and Linking to Outreach Hepatology Care.
    Tien HM; Cheng TC; Lien HC; Yang KF; Shy CG; Chen YL; Hsu NT; Lu SN; Wang JH
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35328957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-Based Screening for Hepatitis B and C Infectivity Using Two Quantitative Antigens to Identify Endemic Townships.
    Huang WC; Lin YC; Chen PJ; Hsu NT; Tu CL; Chang TS; Hung CH; Kee KM; Chao WH; Lu SN
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants.
    Chen CH; Yang PM; Huang GT; Lee HS; Sung JL; Sheu JC
    J Formos Med Assoc; 2007 Feb; 106(2):148-55. PubMed ID: 17339159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of elevated ALT values, HBsAg, and anti-HCV in the primary care setting and evaluation of guideline defined hepatitis risk scenarios.
    Wolffram I; Petroff D; Bätz O; Jedrysiak K; Kramer J; Tenckhoff H; Berg T; Wiegand J;
    J Hepatol; 2015 Jun; 62(6):1256-64. PubMed ID: 25617500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships.
    Kee KM; Chen WM; Hsu NT; Wang JH; Chao WH; Lin YC; Lu SN
    J Formos Med Assoc; 2022 Sep; 121(9):1850-1856. PubMed ID: 35339312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis delta virus and GBV-C infection in two neighboring hepatitis B virus and hepatitis C virus-endemic villages in Taiwan.
    Chang CJ; Chiang JC; Lu SN; Wang JH
    Chang Gung Med J; 2010; 33(2):137-44. PubMed ID: 20438665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in risk factors for being either a hepatitis B carrier or anti-hepatitis C+ in a hepatoma-hyperendemic area in rural Taiwan.
    Wang CS; Chang TT; Chou P
    J Clin Epidemiol; 1998 Sep; 51(9):733-8. PubMed ID: 9731921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA; Farzadegan H; You SL; Lu SN; Wu MH; Wolfe L; Hardy W; Huang GT; Yang PM; Lee H; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):173-8. PubMed ID: 8833617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral hepatitis infections in southern Taiwan: a multicenter community-based study.
    Yang JF; Lin CI; Huang JF; Dai CY; Lin WY; Ho CK; Hsieh MY; Lee LP; Ho NJ; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML; Chuang WL; Chang WY
    Kaohsiung J Med Sci; 2010 Sep; 26(9):461-9. PubMed ID: 20837342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of quantitative hepatitis B surface antigen testing in hepatitis B community-based screening.
    Chang KC; Lee CY; Chang TS; Hung CH; Chen WM; Chen MY; Huang TJ; Chiu WN; Hu JH; Lin YC; Huang WC; Hsu NT; Lu SN
    J Formos Med Assoc; 2021 Feb; 120(2):847-853. PubMed ID: 32896456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected With HBV.
    Liu CJ; Chuang WL; Sheen IS; Wang HY; Chen CY; Tseng KC; Chang TT; Massetto B; Yang JC; Yun C; Knox SJ; Osinusi A; Camus G; Jiang D; Brainard DM; McHutchison JG; Hu TH; Hsu YC; Lo GH; Chu CJ; Chen JJ; Peng CY; Chien RN; Chen PJ
    Gastroenterology; 2018 Mar; 154(4):989-997. PubMed ID: 29174546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas.
    Chen CH; Hsu NT; Chen IC; Chang TS; Cheng S; Cheng SY; Chen HM; Harn MR; Liu CK; Yang MT; Lu SL; Tseng CM; Lu SN
    J Formos Med Assoc; 2024 May; 123(5):613-619. PubMed ID: 38195318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between fatty liver, alanine aminotransferase, HBsAg and hepatitis C virus.
    Chang WY; Chen CJ; Lu SN; You SL; Chuang WL; Chen SC; Su WP; Wang LY; Hsieh MY; Wu MM
    J Gastroenterol Hepatol; 1992; 7(5):455-8. PubMed ID: 1382655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatitis B and C viral infections in Ladakh region.
    Khan MA; Zargar SA; Upadhyay J; Lone TA; Aggarwal R; Bashir G; Ali M; Rabyang S; Namgyal T; Wani ZA
    Indian J Gastroenterol; 2018 Nov; 37(6):504-510. PubMed ID: 30543047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis C antibody carriage and risk of liver impairment in rural-Cameroon: adapting the control of hepatocellular carcinoma for resource-limited settings.
    Kamga Wouambo R; Panka Tchinda G; Kagoue Simeni LA; Djouela Djoulako PD; Yateu Wouambo CI; Tamko Mella GF; Tchoumi Leuwat EP; Bello D; Fokam J
    BMC Infect Dis; 2023 Dec; 23(1):875. PubMed ID: 38093205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
    Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
    BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.